← Back to Search

Behavioral Intervention

Resilience-Building Program for Young Cancer Survivors

N/A

Recruiting

Led By Abby Rosenberg, MD

Research Sponsored by Dana-Farber Cancer Institute

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

All genders ≥ 12 and ≤ 25 years of age at baseline

Be younger than 65 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up at baseline, 3 months, and 6 months

Awards & highlights

Study Summary

This trial aims to help people facing serious illness to better manage their stress and build resilience.

Who is the study for?

This trial is for young individuals aged 12 to 25 who are dealing with anxiety or stress due to a serious illness. They must be able to speak and read English or Spanish, and be cognitively capable of participating in sessions and completing surveys as judged by the investigator.Check my eligibility

What is being tested?

The study tests the 'Promoting Resilience in Stress Management' (PRISM) program, which includes an app with six sessions aimed at teaching skills to manage stress better and improve resilience during tough times.See study design

What are the potential side effects?

Since PRISM is a non-medical intervention focusing on education through an app and coaching, it does not have typical medical side effects. However, participants may experience emotional discomfort while discussing personal stressors.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Select...

I am between 12 and 25 years old.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ at baseline, 3 months, and 6 months

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~at baseline, 3 months, and 6 months

This trial's timeline: 3 weeks for screening, Varies for treatment, and at baseline, 3 months, and 6 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Connor Davidson Resilience Scale (CDRISC-10) Score

Secondary outcome measures

CDRISC-10 Score for App-Only Cohort Responders

CDRISC-10 Score for Text Coach Cohort Responders

Change in Adolescent Participant Quality of Life Total Score

+5 more

Trial Design

3Treatment groups

Experimental Treatment

Active Control

Group I: PRISM Program Mobile AppExperimental Treatment1 Intervention

Participants will be randomized to "app-only" group and will complete: Baseline questionnaire. mPRISM App self guided modules 3 month questionnaire. mPRISM App self guided modules until final survey at 6 months and end of participation.

Group II: PRISM Program Text CoachActive Control2 Interventions

Participants will be randomized to "text" group and will complete: Baseline questionnaire. PRISM sessions. 3 month questionnaire with re-randomization to "app-only," "text," or "video" groups. After re-randomization, participants will complete PRISM sessions until final survey at 6 months and end of participation.

Group III: PRISM Program Video CoachActive Control2 Interventions

Participants will be randomized to "video" group and will complete: Baseline questionnaire. PRISM sessions. 3 month questionnaire with re-randomization to either "app-only" or "text" groups or referral to specialty psychosocial support. After re-randomization, participants will complete PRISM sessions until final survey at 6 months and end of participation.

0 / 1Eligibility criteria met

Find a Location

Who is running the clinical trial?

Dana-Farber Cancer InstituteLead Sponsor

1,080 Previous Clinical Trials

340,908 Total Patients Enrolled

5 Trials studying Anxiety

484 Patients Enrolled for Anxiety

National Cancer Institute (NCI)NIH

13,680 Previous Clinical Trials

40,928,195 Total Patients Enrolled

18 Trials studying Anxiety

12,337 Patients Enrolled for Anxiety

Abby Rosenberg, MDPrincipal InvestigatorDana-Farber Cancer Institute

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

May I be accepted into this research endeavor?

"This clinical trial is selecting participants who are between 12 and 25 years old, have a diagnosis of anxiety disorder, and need 325 people in total."

Answered by AI

Is the age eligibility for this research confined to adults?

"This trial is for participants aged 12 to 25. There are 113 studies available for those under 18 and 359 designed exclusively with the senior population in mind."

Answered by AI

Is this research initiative currently enrolling participants?

"Confirmed, the research posted on clinicaltrials.gov is no longer recruiting patients into this trial as of September 8th 2023. However, there are currently 509 other trials that require enrolment at present."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

Promoting Resilience in Early Survivorship Among Adolescents and Young Adults With Cancer

Abby Rosenberg 2023. "Promoting Resilience in Early Survivorship Among Adolescents and Young Adults With Cancer". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT06038318.